Unique Informatics Technology Improves Workflow Flexibility and Data Integration
Seattle, WA – May 1, 2006 – Teranode Corporation, the leading innovator of scientific data and workflow management software for the Life Sciences industry, today announced the U.S. Patent and Trademark Office (PTO) has issued the company U.S. Patent No. 7,010,760 B2 for a key element of TERANODE XDA. The patent protects the method and apparatus for TERANODE XDA's match rules, a feature for integrating datasets and metadata in dynamic workflow. By automating critical data integration, the match rules enable scientists to quickly and reliably understand the provenance and relationships of data within projects.
Traditional informatics solutions depend on static, predefined schemas and workflows which are brittle and often break down when scientists need to make changes to the design of an experiment. TERANODE XDA accommodates change through an adaptive schema and workflow capability without requiring error-prone, manual data management procedures or expensive reprogramming.
"TERANODE XDA is the first product to integrate process metadata, schema metadata, and instrument data as part of a workflow," said Larry Arnstein, CTO of Teranode. "The match rules technology provides new flexibility in laboratory operations, while providing unrivaled data integration. Once captured, TERANODE XDA leverages semantic web standards to unlock the true potential of the data by enabling analysis, reporting, and search across projects and disciplines."
TERANODE XDA is a powerful informatics platform that leverages existing IT infrastructure to manage scientific data and workflow. TERANODE XDA allows scientists to automate workflow, manage the lifecycle of scientific data, and unify disparate data across laboratories, improving the speed and quality of R&D projects.
About Teranode Corporation
Teranode Corporation, a venture-backed company headquartered in Seattle, Washington, is the leading innovator of scientific data and workflow management software for the Life Sciences industry. Teranode's award-winning products are used by leading pharmaceutical, biotechnology, research, and academic organizations, including Pfizer, AstraZeneca, NIH Chemical Genomics Center, MIT, and Fred Hutchinson Cancer Research Center, to improve the speed and value of experimentation in R&D and then share chemical and biological knowledge enterprise-wide. For more information, visit www.teranode.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.